Loading...
CorMedix Inc.
CRMD•NASDAQ
HealthcareBiotechnology
$13.98
$0.80(6.07%)
CorMedix Inc. (CRMD) Financial Performance & Statements
Review CorMedix Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
54.34%
↑ 54.34%
Net Income Growth
61.31%
↑ 61.31%
Operating Cash Flow Growth
-31.78%
↓ 31.78%
Operating Margin
17.53%
↑ 17.53%
Gross Margin
95.19%
↑ 95.19%
Net Profit Margin
20.81%
↑ 20.81%
ROE
22.57%
↑ 22.57%
ROIC
12.56%
↑ 12.56%
CorMedix Inc. (CRMD) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for CorMedix Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $31.21M | $11.46M | $806119.00 | $0.00 |
| Cost of Revenue | $1.18M | $686598.00 | $509839.00 | $818539.00 |
| Gross Profit | $30.03M | $10.77M | $296280.00 | -$818539.00 |
| Gross Profit Ratio | $0.96 | $0.94 | $0.37 | |
| R&D Expenses | $1.73M | $727119.00 | $650988.00 | $837445.00 |
| SG&A Expenses | $15.37M | $13.33M | $14.95M | $15.05M |
| Operating Expenses | $17.10M | $14.06M | $15.60M | $15.89M |
| Total Costs & Expenses | $18.27M | $14.74M | $16.11M | $16.70M |
| Interest Income | $510385.00 | $553856.00 | $657366.00 | $857186.00 |
| Interest Expense | $10007.00 | $10007.00 | $6556.00 | $9835.00 |
| Depreciation & Amortization | $171840.00 | $114714.00 | $113338.00 | $57470.00 |
| EBITDA | $13.65M | -$2.65M | -$14.03M | -$15.79M |
| EBITDA Ratio | $0.44 | -$0.23 | -$17.41 | |
| Operating Income | $12.94M | -$3.29M | -$15.30M | -$16.70M |
| Operating Income Ratio | $0.41 | -$0.29 | -$18.98 | |
| Other Income/Expenses (Net) | $528396.00 | $510524.00 | $1.15M | $843343.00 |
| Income Before Tax | $13.46M | -$2.78M | -$14.15M | -$15.86M |
| Income Before Tax Ratio | $0.43 | -$0.24 | -$17.56 | |
| Income Tax Expense | $0.00 | $0.00 | $2.00 | -$1.39M |
| Net Income | $13.46M | -$2.78M | -$14.15M | -$14.47M |
| Net Income Ratio | $0.43 | -$0.24 | -$17.56 | |
| EPS | $0.22 | -$0.05 | -$0.25 | -$0.25 |
| Diluted EPS | $0.22 | -$0.05 | -$0.25 | -$0.25 |
| Weighted Avg Shares Outstanding | $61.51M | $58.83M | $57.62M | $57.50M |
| Weighted Avg Shares Outstanding (Diluted) | $61.51M | $58.83M | $57.62M | $57.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan